ArticleDiabetes therapy : research, treatment and education of diabetes and related disorders2025

Can Dual Incretin Receptor Agonists Exert Better Cardiovascular Protection than Selective GLP-1 Receptor Agonists? Highlights from SURPASS-CVOT.

Gian Paolo FadiniPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.